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The distribution of West Nile virus has expanded in the past 6 years to include the 48 contiguous United States and seven Canadian
provinces, as well as Mexico, the Caribbean islands, and Colombia. The suggestion of the emergence of a dominant genetic variant has led to
an intensive analysis of isolates made across North America. We have sequenced the premembrane and envelope genes of 74 isolates and the
complete genomes of 25 isolates in order to determine if a dominant genotype has arisen and to better understand how the virus has evolved
as its distribution has expanded. Phylogenetic analyses revealed the continued presence of genetic variants that group in a temporally and
geographically dependent manner and provide evidence that a dominant variant has emerged across much of North America. The
implications of these findings are discussed as they relate to transmission and spread of the virus in the Western Hemisphere.
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West Nile virus (WNV) (Flaviviridae:Flavivirus) has
recently undergone a dramatic range expansion into much0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2005.07.022
* Corresponding author. Fax: +1 409 772 2500.
E-mail address: abarrett@utmb.edu (A.D.T. Barrett).of North America. Until 1999, the geographical distribu-
tion of the virus was limited to Africa, the Middle East,
India, Australasia, and western and central Asia with
occasional epizootics and epidemics in Europe (Murgue et
al., 2002; Hall et al., 2002). But, since the summer of
1999, the distribution of WNV has expanded to include the
contiguous U.S. states and seven Canadian provinces, as05) 252 – 265
C.T. Davis et al. / Virology 342 (2005) 252–265 253well as Mexico and the Caribbean islands (Estrada-Franco
et al., 2003; Komar et al., 2003; Blitvich et al., 2003;
Dupuis et al., 2003; Quirin et al., 2004) and Colombia
(Komar, personal communication). Because of its relatively
recent introduction, studies concerning the evolution of
WNV are important to understand the extent to which the
virus has mutated as its temporal and geographic distribu-
tion have expanded and to recognize the accumulation of
mutations in the genome that may be important to
transmission and perpetuation of this virus in nature.
Nucleic acid sequencing of WNV isolates collected across
the U.S. since 1999 has identified mutations to the genome
when compared to the prototype New York strain, WN-
NY99 (GenBank accession no. AF196835). These muta-
tions reveal the presence of distinct genetic variants that
group in a temporally and geographically dependent manner
(Lanciotti et al., 2002; Beasley et al., 2003; Davis et al.,
2003; Ebel et al., 2004) and suggest the emergence of a
dominant genetic variant that is now distributed across
much of North America. Additional genetic and phenotypic
studies suggest that the increased isolation frequency of the
dominant genetic variant during 2002 and 2003 may be due
to the possibility of enhanced mosquito transmission
efficiency of this variant in Culex pipiens, one of the main
vectors in the northeastern United States (Ebel et al., 2004).
In order to assess the genetic divergence of WNV as its
spatial and temporal distribution have expanded and to
identify mutations in the WNV genome that may be
conserved in the North American WNV population, we
have characterized both partial and complete genome
sequences of WNV isolates collected from across North
America. The prM and E genes of 74 WNV isolates
collected during 2001–2004 from the U.S., Canada, and
Mexico were sequenced and compared to other North
American WNV sequences available in GenBank. The
complete genomes of 25 isolates were sequenced in order to
attain a more robust comparison of the genetic relationships
of WNV isolates because of the relatively few phylogeneti-
cally informative sites in the prM and E genes of isolates
studied. Sequence alignments were constructed in order to
identify nucleotide and amino acid mutations in the WNV
genome that may support evidence that a dominant genetic
variant has emerged throughout North America. The
individual genes of the WNV were compared to test
whether certain genes may be more prone to the accumu-
lation of mutations and thus may act as surrogates to
complete genome sequencing when performing phyloge-
netic analyses. Phylogenetic trees were generated using both
individual viral gene and complete genomic sequences in
order to compare the relationships among WNV isolates
generated using each method and to identify those genes of
WNV that are the most parsimony informative in the
phylogenetic analysis of North American isolates. Collec-
tively, the data suggest that there has been continued
divergence of WNV as the temporal and spatial distribution
of the virus has expanded.Results
Nucleotide sequencing of North American WNV isolates
The prM and E genes of 74 North American WNV
isolates collected from 2001 to 2004 were sequenced and
new sequences were deposited in GenBank with informa-
tion pertaining to source, collection date, and location of the
isolate (Accession No. DQ158207–DQ158250). The com-
plete genomes of four isolates made from dead birds and
mosquitoes in Texas in 2003 had previously been sequenced
and deposited in GenBank (Accession No. AY712945–
AY712948; Davis et al., 2004). Complete genomes of 21
additional isolates were sequenced and also submitted to
GenBank (Accession no. DQ164186–DQ164206) (Table
1). Table 2 shows the percentage nucleotide and deduced
amino acid sequence divergence among the complete
genomes and ORFs of all newly sequenced WNV isolates
and NY99. All North American West Nile viruses maintain
a high degree of both nucleotide and amino acid sequence
conservation over the complete genome with an average
degree of nucleotide and amino acid divergence from NY99
of 0.24% and 0.09%, respectively. In comparison to NY99,
both the nucleotide and amino acid divergence tended to
increase as the year of isolation increased with the exception
of a few isolates (i.e., TX 2004 Harris 4). The highest degree
of nucleotide divergence from NY99 was 0.39% for AZ
2004, and the degree of amino acid sequence divergence
was highest for NY 2003 Rockland, which had seven amino
acid substitutions from NY99. Overall, the highest degree of
both nucleotide and amino acid divergence was between AZ
2004 and NY 2003 Rockland at 0.58% and 0.38%,
respectively. Interestingly, the degree of nucleotide and
amino acid divergence did not always correlate for a given
isolate because the majority of the nucleotide mutations
were synonymous (data not shown). Each of the 25 isolates
that were completely sequenced had at least one amino acid
substitution relative to the consensus sequence derived from
an alignment of all completely sequenced isolates (Table 3).
In general, isolates made during 2003 and 2004 had
accumulated a larger number of amino acid substitutions
than isolates made in 2001 and 2002. Table 3 shows that the
majority of the isolates share a conserved amino acid
substitution at position E159 from a V Y A with the
exception of some isolates from New York, 2001–2003,
and an isolate from Ohio, 2002. Several amino acid
substitutions were also shared by isolates made in the same
state, though not necessarily the same year. Deduced amino
acid substitutions were identified in each of the 25 isolates
with the largest number of amino acid substitutions
occurring in NS5.
Phylogenetic analysis of WNV isolates
Several phylogenetic trees were generated from prM and
E genes and untranslated regions, as well as complete
Table 1
West Nile virus isolates sequenced for this study
Abbreviation Isolate Year of
isolation
Location Source Passage
history
Genbank
accession
no.
FL 2001 Palm Beach Florida 2001 2001 Palm Beach, Florida Catbird V2 DQ080072
NY 2001 Suffolk 32010157 2001 Suffolk Co., NY Culex pipiens/restuans V1 DQ164194
FL 2002 Sumter Florida 2002 2002 Sumter, Florida Horse V2 DQ080071
NY 2002 Queens 02003011 2002 Queens Co., NY American crow P DQ164186
NY 2002 Broome 02003557 2002 Broome Co., NY American crow P DQ164187
NY 2002 Clinton 02002758 2002 Clinton Co., NY American crow P DQ164193
NY 2002 Nassau 34020055 2002 Nassau Co., NY Culex pipiens/restuans V2 DQ164195
Ontario 2002 Ontario 2002 Ontario, Canada American crow V2 DQ158245
Saskatchewan 2002 Saskatchewan 2002 Saskatchewan, Canada Black-billed magpie V2 DQ158246
Manitoba 2002 Manitoba 2002 Manitoba, Canada Amercican crow V2 DQ158244
GA 2002 1 68955 2002 Georgia Human—plasma P DQ164196
GA 2002 2 68960 2002 Georgia Human—brain P DQ164197
OH 2002 81948 2002 Ohio Human—plasma P DQ164202
IN 2002 81931 2002 Indiana Human—plasma P DQ164200
TX 2002 1 80025 2002 Texas Human—plasma P DQ164198
TX 2002 2 80022 2002 Texas Human—plasma P DQ164205
NY 2003 Westchester 03000360 2003 Westchester Co., NY Amercican crow P DQ164188
NY 2003 Alabany 03001986 2003 Albany Co., NY American crow P DQ164189
NY 2003 Suffolk 03002018 2003 Suffolk Co., NY American crow P DQ164190
NY 2003 Chautauqua 03002086 2003 Chautauqua Co., NY American crow P DQ164191
NY 2003 Rockland 03002094 2003 Rockland Co., NY American crow P DQ164192
AZ 2003 1 03-az-mp-1623 2003 Arizona Magpie V1 DQ158207
AZ 2003 2 03-az-mp-1681 2003 Arizona Magpie V1 DQ158208
AZ 2003 3 03-az-mp-1799 2003 Arizona Magpie V1 DQ158209
CA 2003 Los Angeles 1 03-ca-crow-s0331532 2003 Los Angeles Co., CA American crow V1 DQ158210
CA 2003 Los Angeles 2 03-ca-crow-s0334814 2003 Los Angeles Co., CA American crow V1 DQ158211
CA 2003 Los Angeles 3 Mosq. grla1131 2003 Los Angeles Co., CA Culex tarsalis V2 DQ158212
CA 2003 Los Angeles 4 03-ca-mp-grla-1260 2003 Los Angeles Co., CA Magpie V1 DQ158214
CA 2003 Los Angeles 5 Bird 9173 2003 Los Angeles Co., CA American crow V2 DQ158217
CA 2003 San Bernadino Bird 9172 2003 San Bernadino Co., CA American crow V2 DQ158218
CA 2003 1 03-ca-mp-impr-102 2003 Imperial Valley, CA Magpie V1 DQ158215
CA 2003 2 03-ca-mp-impr-1075 2003 Imperial Valley, CA Magpie V1 DQ158216
CA 2003 3 Mosq. impr1143 2003 Imperial Valley, CA Culex tarsalis V2 DQ158213
MX 2003 Nuevo Leon Mosq. 9488 2003 Nuevo Leon, Mexico Culex quinquefasciatus V2 AY963775
CO 2003 Larimer Bird 9185 2003 Larimer Co., CO Culex pipiens V2 DQ158219
CO 2003 1 Colorado 3068 2003 Colorado Red-tailed hawk P DQ164204
CO 2003 2 Colorado 3258 2003 Colorado Magpie P DQ164203
NB 2003 Brown Bird 9239 2003 Brown Co., Nebraska Bluejay V2 DQ158236
NB 2003 Dakota Bird 9241 2003 Dakota Co., Nebraska Bluejay V2 DQ158237
TX 2003 Harris 1 Bird 9045 2003 Harris Co., TX Bluejay V1 DQ158223
TX 2003 Harris 2 Bird 9114 2003 Harris Co., TX Bluejay V1 DQ158222
TX 2003 Harris 3 Mosq. V4095 2003 Harris Co., TX Culex quinquefasciatus V1 DQ158224
TX 2003 Harris 4 Mosq. V4369 2003 Harris Co., TX Culex quinquefasciatus V1 AY712948
TX 2003 Harris 5 Mosq. V4096 2003 Harris Co., TX Culex quinquefasciatus V1 DQ158226
TX 2003 Harris 6 Bird 1153 2003 Harris Co., TX Mourning dove V1 AY712945
TX 2003 Harris 7 Bird 1171 2003 Harris Co., TX Great-tailed grackle V1 AY712946
TX 2003 Harris 8 Bird 1175 2003 Harris Co., TX Bluejay V1 DQ158220
TX 2003 Harris 9 Bird 1240 2003 Harris Co., TX Bluejay V1 DQ158221
TX 2003 Harris 10 Bird 1461 2003 Harris Co., TX Bluejay V1 AY712947
TX 2003 Harris 11 Mosq. V4370 2003 Harris Co., TX Culex quinquefasciatus V1 DQ158225
TX 2003 Montgomery 1 Bird 1519 2003 Montgomery Co., TX Bluejay V1 DQ158227
TX 2003 Montgomery 2 Bird 1574 2003 Montgomery Co., TX Bluejay V1 DQ158228
TX 2003 Montgomery 3 Bird 1576 2003 Montgomery Co., TX Bluejay V1 DQ158229
TX 2003 Jefferson 1 Bird 1881 2003 Jefferson Co., TX Mourning Dove V1 DQ158230
TX 2003 Jefferson 2 Bird 2073 2003 Jefferson Co., TX Bluejay V1 DQ158231
TX 2003 Wharton Bird 2071 2003 Wharton Co., TX Bluejay V1 DQ158232
TX 2003 Texas 82229 2003 Texas Human—plasma P DQ164199
LA 2004 New Iberia Bird 2409 2004 New Iberia Parish, Louisiana Northern cardinal V2 DQ080061
IL 2004 Madison Illinois—9515 2004 Madison Co., Illinois American crow V2 DQ158250
IL 2004 Schuyler Illinois—9517 2004 Schuyler Co., Illinois American crow V2 DQ158249
IL 2004 Knox Illinois—9519 2004 Knox Co., Illinois Bluejay V2 DQ158248
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Abbreviation Isolate Year of
isolation
Location Source Passage
history
Genbank
accession
no.
IL 2004 New Marion Illinois—9520 2004 New Marion Co., Illinois Bluejay V2 DQ158247
AZ 2004 Arizona 2004 2004 Arizona Human—plasma P DQ164201
MX 2004 Sonora Mexico 2004 2004 Sonora, Mexico Human—plasma V2 AY963774
TX 2004 Harris 1 Bird 2419 2004 Harris Co., TX Bluejay V1 DQ158233
TX 2004 Harris 2 Bird 2541 2004 Harris Co., TX Mourning dove V1 DQ158234
TX 2004 Harris 3 Bird 3218 2004 Harris Co., TX Bluejay V1 DQ158235
TX 2004 Harris 4 Bird 3588 2004 Harris Co., TX Bluejay V1 DQ164206
TX 2004 Parmer Bird 9460 2004 Parmer Co., TX House sparrow V1 DQ158238
TX 2004 Brazoria 1 Bird 9461 2004 Brazoria Co., TX Bluejay V1 DQ158239
TX 2004 Brazoria 2 Bird 9473 2004 Brazoria Co., TX Bluejay V1 DQ158241
TX 2004 Swisher Bird 9472 2004 Swisher Co., TX House sparrow V1 DQ158240
TX 2004 Randall Bird 9477 2004 Randall Co., TX House sparrow V1 DQ158242
TX 2004 Galveston Bird 9483 2004 Galveston Co., TX Bluejay V1 DQ158243
Isolates in bold have been completely sequenced. P = RNA extracted from infected tissue. V1 = RNA extracted from original isolation in Vero cells. V2 = RNA
extracted after single Vero cell passage.
Table 1 (continued)
C.T. Davis et al. / Virology 342 (2005) 252–265 255genomes in order to ascertain the phylogenetic relationships
of the isolates studied. RT-PCR was used to sequence a
2004 nucleotide region of the prM and E genes of 74 WNV
isolates to broaden the scope of our phylogenetic analysis
because there are a larger number of partial sequences
(primarily the prM and E genes) of WNV isolates available
in GenBank. A Bayesian analysis was used to generate a
consensus tree based on the prM and E alignment of these
74 North American WNV isolates in comparison to all other
North American WNV isolates for which the prM and E
sequence was available in GenBank (Fig. 1). The tree was
rooted with the most closely related Old World WNV, Israel-
1998 (Accession no. AY033389) in order to generate a tree
illustrating more parsimony informative sites. This analysis
revealed three distinct clades comprised of North American
isolates. The apical clade was comprised of isolates
collected from all over North America which were collected
from 2002 to 2004 and has been termed the ‘‘North America
2002–2004’’ clade. Within this clade were many subclades,
which consisted of isolates that were highly conserved at the
nucleotide sequence level and some which were identical to
one another. Most of the isolates within these subclades
were made in the same state and during the same year,
although there was evidence that some isolates made in
close geographic proximity tended to cluster into subclades.
Basal to the North American 2002–2004 clade was a sister
clade that represents an intermediate grouping of isolates
that share some degree of sequence identity with the North
American 2002–2004 clade. This sister clade was made up
primarily of isolates from eastern regions of the U.S.
including New York, Alabama, Indiana, Illinois, Louisiana,
and eastern Texas. An isolate from Tabasco State, Mexico
made up a second sister clade because of a conserved
nucleotide substitution at position 2466 in the envelope
protein gene that was also found in all apical isolates. Two
additional Mexican isolates from Sonora State and Nuevo
Leon State did not group with the isolate from TabascoState, which again suggests the occurrence of multiple
introductions of WNV into Mexico as has been noted by
others (Estrada-Franco et al., 2003; Blitvich et al., 2004).
Interestingly, both of the Mexican isolates fall into the most
apical clade, which also contains isolates collected from
Arizona in 2003 and 2004, several isolates collected in
Texas in 2004, and an isolate from Colorado in 2003. A
second clade, termed the ‘‘Eastern U.S.’’ clade, was
comprised of isolates collected from the Eastern U.S. states.
The majority of these isolates were made prior to 2003, with
the exception of two isolates from New York. This clade
also contained isolates from the Northeastern U.S. that were
made during the early stages of the WNV epidemic
including isolates from New York in 1999. Although
genetically more distantly related to Israel-1998 than the
Eastern U.S. isolates, the most basally positioned clade was
comprised of ‘‘Southeast coastal Texas’’ isolates from 2002.
The basal position of this clade occurred as a result of
several non-parsimony informative nucleotide mutations
shared by isolates in the Eastern U.S. clade and the North
American 2002–2004 clade, none of which were found in
the Southeast coastal Texas 2002 clade. Interestingly,
isolates made from the southeast coast of Texas in 2003
and 2004 belonged to the North American 2002–2004
clade, suggesting that this genotype has become extinct or
displaced in this particular region.
To further define the phylogenetic relationships among
North American WNV isolates and to confirm the relation-
ships as delineated by the prM and E sequences, the
complete genomic sequencing of 25 isolates was undertaken
to provide a more robust comparison. A phylogenetic tree
was generated by maximum likelihood analysis to show the
relationship between the newly sequenced isolates and those
North American isolates available in GenBank. A total of 36
North American WNV isolates from this and previous
studies group in a monophyletic clade of the Lineage I
WNV strains, which sits just apical to the closest related Old
able 2
ercentage nucleotide/amino acid divergence over the complete genome/ORF among WNV isolates
NY99AF196835 NY
2001
Suffolk
NY
2002
Nassau
NY
2002
Clinton
NY
2002
Queens
NY
2002
Broome
GA
2002
1
GA
2002
2
TX
2002
1
TX
2002
2
IN
2002
OH
2002
NY
2003
Westchester
NY
2003
Albany
NY
2003
Suffolk
NY
2003
Chautauqua
NY
2003
Rockland
3
CO
2003
2
TX
2003
TX
2003
Harris
4
TX
2003
Harris
6
TX
2003
Harris
7
TX
2003
Harris
10
AZ
2004
TX
2004
Harris
4
Y99AF196835 0.15 0.18 0.18 0.17 0.24 0.24 0.23 0.23 0.23 0.16 0.30 0.18 0.25 0.28 0.22 0.26 2 0.34 0.25 0.24 0.33 0.35 0.25 0.39 0.21
Y 2001
Suffolk
0.06 0.28 0.28 0.27 0.34 0.34 0.33 0.33 0.33 0.26 0.40 0.26 0.35 0.38 0.32 0.36 2 0.41 0.35 0.34 0.43 0.45 0.35 0.49 0.34
Y 2002
Nassau
0.06 0.12 0.15 0.12 0.33 0.21 0.19 0.17 0.17 0.13 0.34 0.31 0.22 0.23 0.18 0.35 8 0.31 0.20 0.21 0.29 0.32 0.20 0.35 0.26
Y 2002
Clinton
0.06 0.12 0.06 0.14 0.34 0.17 0.15 0.15 0.15 0.13 0.35 0.31 0.22 0.23 0.15 0.37 6 0.29 0.18 0.17 0.27 0.30 0.20 0.32 0.28
Y 2002
Queens
0.03 0.09 0.03 0.03 0.32 0.20 0.18 0.16 0.16 0.10 0.33 0.30 0.21 0.20 0.17 0.34 7 0.30 0.19 0.20 0.28 0.31 0.19 0.34 0.25
Y 2002
Broome
0.15 0.20 0.20 0.20 0.17 0.41 0.39 0.37 0.37 0.33 0.44 0.36 0.42 0.43 0.38 0.19 8 0.49 0.40 0.41 0.45 0.48 0.40 0.55 0.41
A 2002 1 0.06 0.12 0.06 0.06 0.03 0.20 0.02 0.22 0.22 0.19 0.42 0.37 0.28 0.31 0.21 0.44 3 0.35 0.23 0.22 0.34 0.36 0.26 0.38 0.34
A 2002 2 0.03 0.09 0.03 0.03 0.00 0.17 0.03 0.20 0.20 0.17 0.40 0.35 0.26 0.29 0.19 0.42 1 0.34 0.21 0.20 0.32 0.34 0.24 0.36 0.33
X 2002 1 0.09 0.15 0.09 0.09 0.06 0.23 0.09 0.06 0.02 0.17 0.38 0.35 0.26 0.27 0.19 0.40 9 0.32 0.21 0.22 0.30 0.33 0.23 0.36 0.31
X 2002 2 0.12 0.17 0.12 0.12 0.09 0.26 0.12 0.09 0.03 0.17 0.38 0.35 0.26 0.27 0.19 0.40 9 0.32 0.21 0.22 0.30 0.33 0.23 0.36 0.31
N 2002 0.03 0.09 0.03 0.03 0.00 0.17 0.03 0.00 0.06 0.09 0.34 0.29 0.20 0.23 0.16 0.35 6 0.31 0.20 0.19 0.27 0.30 0.20 0.34 0.26
H 2002 0.06 0.12 0.12 0.12 0.09 0.20 0.12 0.09 0.15 0.17 0.09 0.43 0.43 0.44 0.37 0.47 5 0.50 0.41 0.40 0.48 0.51 0.41 0.56 0.45
Y 2003
Westchester
0.09 0.15 0.15 0.15 0.12 0.23 0.15 0.12 0.17 0.20 0.12 0.15 0.38 0.41 0.34 0.39 4 0.44 0.38 0.37 0.45 0.48 0.38 0.50 0.37
Y 2003
Albany
0.09 0.15 0.09 0.09 0.06 0.23 0.09 0.06 0.12 0.15 0.06 0.15 0.17 0.32 0.25 0.44 5 0.40 0.29 0.28 0.36 0.39 0.29 0.43 0.35
Y 2003
Suffolk
0.09 0.15 0.09 0.09 0.06 0.23 0.09 0.06 0.12 0.15 0.06 0.15 0.17 0.12 0.28 0.45 8 0.41 0.30 0.31 0.39 0.42 0.30 0.44 0.36
Y 2003
Chautauqua
0.03 0.09 0.03 0.03 0.00 0.17 0.03 0.00 0.06 0.09 0.00 0.09 0.12 0.06 0.06 0.41 6 0.33 0.22 0.19 0.31 0.34 0.24 0.35 0.32
Y 2003
Rockland
0.20 0.26 0.26 0.26 0.23 0.12 0.26 0.23 0.29 0.32 0.23 0.26 0.29 0.29 0.29 0.23 1 0.52 0.43 0.44 0.50 0.53 0.43 0.58 0.44
O 2003 1 0.03 0.09 0.03 0.03 0.00 0.17 0.03 0.00 0.06 0.09 0.00 0.09 0.12 0.06 0.06 0.00 0.23 0.44 0.34 0.31 0.32 0.34 0.34 0.44 0.42
O 2003 2 0.15 0.20 0.15 0.15 0.12 0.29 0.15 0.12 0.17 0.20 0.12 0.20 0.23 0.17 0.17 0.12 0.35 2 0.34 0.35 0.45 0.48 0.36 0.44 0.43
X 2003 0.06 0.12 0.06 0.06 0.03 0.20 0.06 0.03 0.09 0.12 0.03 0.12 0.15 0.09 0.09 0.03 0.26 3 0.15 0.24 0.34 0.37 0.25 0.39 0.34
X 2003
Harris 4
0.12 0.17 0.12 0.12 0.09 0.26 0.12 0.09 0.15 0.17 0.09 0.17 0.20 0.15 0.15 0.09 0.32 9 0.20 0.12 0.34 0.36 0.26 0.38 0.34
X 2003
Harris 6
0.12 0.17 0.12 0.12 0.09 0.26 0.12 0.09 0.15 0.17 0.09 0.17 0.20 0.15 0.15 0.09 0.32 9 0.20 0.12 0.17 0.03 0.34 0.48 0.43
X 2003
Harris 7
0.17 0.23 0.17 0.17 0.15 0.32 0.17 0.15 0.20 0.23 0.15 0.23 0.26 0.20 0.20 0.15 0.38 5 0.26 0.17 0.23 0.06 0.37 0.51 0.45
X 2003
Harris 10
0.15 0.20 0.15 0.15 0.12 0.29 0.15 0.12 0.17 0.20 0.12 0.20 0.23 0.17 0.17 0.12 0.35 2 0.23 0.15 0.20 0.20 0.26 0.41 0.32
Z 2004 0.17 0.23 0.17 0.17 0.15 0.32 0.17 0.15 0.20 0.23 0.15 0.23 0.26 0.20 0.20 0.15 0.38 5 0.20 0.17 0.23 0.23 0.29 0.26 0.49
X 2004
Harris 4
0.09 0.15 0.09 0.09 0.06 0.23 0.09 0.06 0.12 0.15 0.06 0.15 0.17 0.12 0.12 0.06 0.29 6 0.17 0.09 0.15 0.15 0.20 0.12 0.20
ercentage nucleotide divergence displayed in boldface; amino acid divergence displayed in regular type.
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Table 3
Deduced amino acid substitutions from WN-NY99 found in each completely sequenced isolate
Residue WN-
NY99
NY
2001
Suffolk
NY
2002
Nassau
NY
2002
Clinton
NY
2002
Queens
NY
2002
Broome
GA
2002
1
GA
2002
2
TX
2002
1
TX
2002
2
IN
2002
OH
2002
NY
2003
Westchester
NY
2003
Albany
NY
2003
Suffolk
NY
2003
Chautauqua
NY
2003
Rockland
CO
2003
1
CO
2003
2
TX
2003
TX
2003
Harris 4
TX
2003
Harris 6
TX
2003
Harris 7
TX
2003
Harris 10
AZ
2004
TX
2004
Harris 4
CAP-59 Ile Val
CAP-67 Asp Asn
CAP-90 Thr Ala
prM-4 Asn Asp
prM-156 Val Ile Ile
E-159 Val Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala
E-169 Ile Val
E-176 Tyr His His
E-178 Leu Gln
E-188 Thr Ala
E-208 Thr
E-263 His Gln
NS1-111 Leu Phe
NS1-135 Val Ile Ile
NS1-144 Pro Ser
NS1-254 His Tyr
NS2A-34 Met Leu Leu
NS2A-102 Gln His His
NS2A-224 Ala Thr
NS2B-84 Asn Asp
NS3-106 Val Ala
NS3-328 Glu Lys
NS3-336 Leu
NS3-486 Phe Leu Ser
NS3-539 Arg Lys
NS3-603 Ser
NS4A-3 Ile Met Leu
NS4A-85 Ala Thr Thr
NS4A-135 Val Met
NS4B-83 Ala Ser
NS4B-119 Phe Leu Leu
NS4B-202 Ile Thr
NS4B-240 Ile Met Met
NS4B-241 Thr Ala
NS4B-245 Ile Val
NS4B-249 Glu Gly Gly
NS5-200 Arg Leu
NS5-277 Ser Arg
NS5-287 Arg Lys
NS5-296 His Tyr
NS5-314 Lys Arg
NS5-531 Lys Arg
NS5-560 Ala Ser
NS5-619 Ala Ser
NS5-688 Ala Asp
NS5-804 Ala Val Val
Total 3 2 2 1 4 2 1 3 3 1 2 3 3 2 1 7 1 5 1 4 4 6 4 6 3
Amino acid positions determined from the sequence alignment of the 25 completely sequenced isolates in comparison to WN-NY99 (Accession no. AF196835).
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Fig. 1. Phylogenetic tree constructed by Bayesian analysis of prM and E genes (2004 ntds.) of 108 North American WNV isolates.
C.T. Davis et al. / Virology 342 (2005) 252–265258World strain, Israel-1998. The complete genome analysis
generated a tree that also illustrates the presence of the
North American 2002–2004 clade, relative to the Eastern
U.S. clade and illustrates the presence of more highly
resolved subclades within each of the larger clades. As was
noted in the prM and E gene tree, the majority of fullyresolved subclades were comprised of isolates that were
made in the same geographic region and during the same
year. It is interesting to note that the complete genome
analysis placed an isolate from the southeast coast of Texas
in the same clade as other isolates from the Eastern U.S.
Because of the lack of nucleotide mutations in isolates
C.T. Davis et al. / Virology 342 (2005) 252–265 259belonging to the Eastern U.S. clade relative to the North
American 2002–2004 clade, sub-groupings were less
resolved and the clade consisted of a large polytomy.
Interestingly, the resolved sub-groupings were comprised of
northeastern isolates that were made primarily in 2002 and
2003. Also of interest was an intermediate clade found
between the two larger clades that is comprised of an isolate
from Tabasco State, Mexico, an isolate from Ohio, 2002,
and an isolate from New York, 2000, indicating the
likelihood that additional clades within the North AmericanFig. 2. Phylogenetic tree generated by maximum likelihood analysis of an alignme
isolates with other U.S. and Old World isolates.monophyletic clade will continue to be identified as additio-
nal genome sequences become available (Fig. 2).
Fig. 3 shows two additional phylogenetic trees that
represent the overall tree topology generated from analyses
of each of the individual genes and untranslated regions of
the WNV genome. Bootstrap values are shown only at
clades and subclades that were resolved in each of the
trees generated by analysis of individual genes or regions.
The ‘‘group B’’ topologies are similar to those seen in the
complete genome analysis in that the two large clades cannt of the complete genomes of 25 newly sequenced North American WNV
ig. 3. Representative phylogenetic trees generated by maximum likelihood analysis of each of the individual WNV genes, and untranslated regions sho g presence or absence of clade topology with North
merican, 2002–2004 clade separate from Eastern U.S. clade. Group ‘‘A’’ represents tree topology generated from analyses of 5VUTR, capsid, NS1, B, and NS4A. Group ‘‘B’’ represents tree topology
enerated from analyses of prM, E, NS2A, NS3, NS4B, NS5, and 3VUTR.
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Table 4
Nucleotide mutations conserved in all isolates of North American clade 2002–2004 relative to WN-NY99
5VUTR Capsid prM E NS1 NS2A NS2B NS3 NS4A NS4B NS5 3VUTR
None None 660 (C to U) 1442 (U to C)a None 3774 (U to C) None 4803 (C to U) None 6996 (C to U) 7938 (U to C) 10851 (A to G)
4146 (A to G) 6138 (C to U) 9352 (C to U)
2466 (C to U) 6238 (C to U)
6426 (C to U)
Nucleotide positions correspond to WN-NY99.
a Encodes E159 (Val to Ala) amino acid substitution.
C.T. Davis et al. / Virology 342 (2005) 252–265 261be readily distinguished from one another with average
bootstrap values >85. The group B topology was generated
from analyses of the prM, E, NS2A, NS3, NS4B, NS5,
and 3VUTR. In contrast, ‘‘group A’’ trees (generated from
analyses of the 5VUTR, capsid, NS1, NS2B, and NS4A) do
not delineate between the two clades and illustrate only the
monophyletic North American clade relative to Old World
isolates. Furthermore, group A trees do not place Israel-
1998 as a distinct outlier to the North American clade. A
lack of parsimony informative mutations within certain
genes or untranslated regions is likely to relate to the lack
of topology seen in the group A trees. Accordingly, the
complete genome alignment of the completely sequenced
WNV isolates was used to identify the nucleotide and
deduced amino acid mutations that are conserved in
isolates belonging to the North American 2002–2004
clade. Table 4 shows that no conserved mutations have
accumulated in the genes (capsid, NS1, NS2B, and NS4A)
or untranslated region (5VUTR) that produce trees with no
resolution of clade topology. In contrast, at least one
nucleotide mutation is conserved in individual genes or the
untranslated region that results in trees that show the
presence of multiple clades. The largest number of
conserved mutations was found in the NS3 gene. Despite
the occurrence of 13 nucleotide mutations in each of the
isolates belonging to the North American 2002–2004
clade, there has been only a single amino acid substitution
conserved in these isolates (E-V159A).Discussion
Since the detection of WNV in the U.S. in 1999, studies
concerning the molecular epidemiology of the virus have
proven useful for tracing the geographic and temporal
spread and interhost transmission of the virus (Davis et al.,
2003; Ebel et al., 2004; Solomon et al., 2003; Estrada-
Franco et al., 2003; Blitvich et al., 2004) and in detecting
phenotypic variants (Beasley et al., 2004; Davis et al., 2004;
Ebel et al., 2004). Because the location and year of the first
virus isolations have been well documented (Lanciotti et al.,
1999, 2002), it has been possible to make genetic and
phenotypic comparisons between isolates made at the onset
of the North American WNV epizootic and isolates made
from all subsequent years and over a broad geographic
distribution (Anderson et al., 2001; Beasley et al., 2003;Davis et al., 2003, 2004; Ebel et al., 2001, 2004).
Consequently, genome sequences of isolates made in 1999
and 2000 provide a genetic baseline allowing for the
identification of novel mutations to the genomes of more
recently isolated strains, which can then be used to infer
phylogenetic relationships among isolates. Previous phylo-
genetic studies have focused on sequencing complete
genomes of virus isolates from the Northeastern U.S. and
only partial sequences (primarily the prM and/or E genes) of
isolates from other regions of North America. Accordingly,
this study has relied on both partial and complete genome
sequences of isolates in order to further characterize the
phylogenetic relationships of North American WNV isolates
and to better understand how this virus has evolved since its
introduction 6 years ago.
Our laboratories sequenced the prM and E genes of the
genome for 74 North American isolates because previous
studies of WNV molecular epidemiology have relied on
sequencing of this region. Furthermore, because of the
relatively few complete nucleotide sequences of North
American WNV isolates available for analysis prior to this
study, we have sequenced complete genomes of isolates
representing a wide range of host species, collection years,
and locations. Although the prM and E gene sequences
demonstrate an accurate and reliable phylogenetic repre-
sentation, analysis of complete genomes of North American
WNV isolates provides a more robust comparison of the
evolutionary relationships between isolates and reveals
additional mutations to the WNV genome that may have
implications for the phenotypic properties that these isolates
express (Davis et al., 2004; Beasley et al., 2004; Ebel et al.,
2004). Moreover, complete genome analysis allows one to
compare isolates at the individual gene level in order to
identify those genes which may be more reliable for the
comparison of parsimony informative sites among isolates.
Therefore, this study has used a variety of methods to infer
phylogenetic relationships of North American WNV isolates
and to further define the evolution of WNV.
Data from complete nucleotide and amino acid sequence
analysis supports previous findings suggesting that WNV
has continued to diverge from progenitor isolates (those
made in the Northeastern U.S. at the early stages of WNV
spread) as the temporal and geographic distribution of the
virus has expanded. It was also evident from this analysis
that isolates displaying the highest degree of nucleotide and
amino acid sequence divergence, in general, were collected
C.T. Davis et al. / Virology 342 (2005) 252–265262after 2002. This may be significant as 2002 was the year of
the largest recorded epidemic of arboviral encephalitis in
North America and saw a vast geographic expansion by the
virus (CDC, 2002). The nucleotide divergence may reflect
the nature of the error-prone polymerase of WNV in that as
the virus continues to replicate over time and geographic
location, additional mutations to the genomes of viruses will
continue to arise. Although the majority of these mutations
are silent, it is apparent from this and other studies that
amino substitutions are not uncommon and have resulted in
phenotypic variation within the North American WNV
population (Beasley et al., 2004; Davis et al., 2004; Ebel et
al., 2004). Despite the continuing divergence of the virus
from progenitors, many of the accumulated nucleotide
mutations to the genome have become fixed in currently
circulating viruses. Many of these fixed mutations were
found in isolates from Georgia, Texas, and Indiana in 2002
indicating their presence since at least 2002 and were most
likely found in those viruses that were circulating at the
forefront of the western expansion of the virus. Conse-
quently, all isolates sequenced from the western U.S.
contain the majority of those fixed mutations shown in
Table 4, a result which may reflect the rapid westward
progression of the virus from 2002 to 2004. In contrast,
there has been only a single conserved amino acid
substitution (E-V159A) shared in the majority of isolates
sequenced for this study, perhaps reflecting the inability of
the virus population to sustain substitutions in viral proteins
which may be disadvantageous to viral fitness. Incidentally,
this particular substitution is found in many Old World
WNV strains (data not shown) and may represent a non-
critical residue that has reverted back to a residue common
in ancestral strains. Undoubtedly, as the virus continues to
evolve, additional amino acid substitutions will become
fixed in the population at large, the consequences of which
remain speculative at this point.
Phylogenetic analysis of prM and E gene sequences
revealed three distinct clades within the North American
WNV monophyletic group. As noted by previous studies,
the majority of isolates collected since 2002 belong to a
single clade that has been termed the North American
2002–2004 clade. The emergence of this clade appears to
correspond with the increased intensity of transmission and
western progression of WNV across the U.S. during 2002
and indicates that, as the distribution of the virus expanded,
mutations to the genomes of circulating viruses began to
accumulate and became fixed in the overall virus popula-
tion. The finding that the majority of isolates made from
2002 to 2004 belong to this clade suggests the emergence of
a dominant genetic variant whose distribution is now
uniform across all of North America. It is also apparent
that this variant has began to replace other genetic variants
in certain regions (i.e., Eastern U.S. and Southeast coastal
Texas variants). Findings by Ebel et al. (2004) suggest that
this displacement and rapid spread may be correlated with
increased transmission efficiency of the dominant geneticvariant in Culex spp. mosquitoes when compared to other
variants. Additional phenotypic studies will be required to
characterize any fitness advantages that this variant may
have over others.
Analysis of the prM and E genes of North American
WNV isolates also separated many isolates of the North
American 2002–2004 clade into subclades that represent
isolates from certain regions of North America. Of note was
a subclade consisting of isolates from Mexico, Arizona, and
Texas, suggesting that transmission of viruses in those
regions may be the result of localized virus spread by
resident birds rather than by migratory birds that may
introduce more distantly related viruses into a particular
area. Although not always the case, several subclades were
made up of isolates from the same state during the same
year, illustrating that genetic distance among WNV isolates
often reflects geographic and temporal distances. In
contrast, some intermediate clades, as illustrated in the
complete genome tree, may also represent the long-distance
spread of WNV by migratory birds, in contrast to the more
localized spread by non-migratory species. Evidence that
migratory birds are capable of the dispersal of discrete
genetic variants over long distances is supported by the
close genetic relatedness of the Tabasco isolate to a 2002
Ohio isolate.
As was noted by Blitvich et al. (2004), Bayesian
analysis of WNV isolates that differ by only a few
informative sites can be used as a more efficient method
for the generation of equally or more robust phylogenetic
trees in comparison to more commonly used phylogenetic
methods (i.e., parsimony, likelihood analysis). Similar
topologies were created by maximum parsimony, neigh-
bor-joining, and Bayesian methods, and the Bayesian
analysis generated equally or more significant confidence
values at internal nodes. Bayesian analysis was preferred to
other methods because the analysis was also less computa-
tionally exhaustive due to the large number of isolates
compared in the prM and E sequence alignment. While
analysis using complete genome sequences is clearly the
most informative method of describing evolutionary rela-
tionships among viral isolates, a lack of complete sequences
in public databases makes this technique less useful. Thus,
Bayesian analysis may provide a more efficient method
for describing the relationships between WNV isolates
that share high nucleotide identities with few informative
sites.
Complete nucleotide sequence analysis revealed similar
tree topology as that found in the analysis of prM and E
genes. The North American monophyletic group in
comparison to Old World isolates remained divided into
two separate clades, the North American 2002–2004 and
Eastern U.S. clade. It is likely that the Southeast coastal
Texas clade was not resolved by the complete genome
analysis because only a single isolate from this clade has
been completely sequenced. The results demonstrate that
all isolates collected after 2002 with the exception of a few
C.T. Davis et al. / Virology 342 (2005) 252–265 263isolates from New York in 2003 are contained in the North
American 2002–2004 clade. Thus, it is evident from the
complete genome analysis that a dominant WNV variant
has emerged in all of the regions sampled in this study.
This analysis also reveals that isolates collected in close
spatial and temporal proximity cluster in discrete sub-
clades. Despite the existence of a large polytomy in the
Eastern U.S. clade, the more highly evolved North
American clade contains more fully resolved subclades,
again suggesting that isolates collected outside of the
Northeastern U.S. and after 2002 depict the continuing
divergence of isolates from progenitors and that their
phylogenetic relationships can be more resolved because of
a larger number of conserved mutations to their genomes.
The existence of these groupings continues to suggest that
the rate of evolution (albeit on a microevolutionary scale)
occurring between transmission seasons and as WNV
spreads from region to region is rapid enough to drive
the emergence of genetic variants and is likely to continue
to do so as the virus distribution increases. Even though
the overall tree topology was conserved between the prM
and E gene analysis and the complete genome analysis,
when using alignments of individual genes or untranslated
regions, the phylogenetic relationships of North American
West Nile viruses become less clear. While analyses of
certain genes or untranslated regions were able to generate
the topologies illustrated by complete genome or prM and
E analyses, many did not. Furthermore, in those analyses
that did result in tree topology demonstrating the separa-
tion of clades, the resolution of subclades was far less
pronounced. The differences in tree topology based on
individual genes and untranslated regions may also reflect
the ability of some genes or untranslated regions to
withstand mutations to the genome, while others are
unable to withstand mutations because of structural or
functional constraints. Alternatively, the rates of evolution
of individual genes or untranslated regions may differ
because of selective pressures that drive the evolution of
certain genes/regions. Thus, while certain individual genes
or untranslated regions may be able to act as surrogates to
complete genomes when conducting phylogenetic analy-
ses, combinations of genes appear to provide a more
accurate depiction of genetic relatedness among isolates in
lieu of complete genome sequencing. Despite this finding,
it is likely that, as more sequence data become available
for isolates, the topologies derived from the analysis of
each gene or untranslated region will become more
consistent. As additional sequence information becomes
available from geographic regions underrepresented by this
study and in regions where WNV isolates have yet to be
obtained for sequencing (i.e., Caribbean islands and
Central America), the molecular epidemiology of this
emerging virus will continue to be defined. This and
previous studies have provided a database of sequence
information which can be utilized in the future to trace the
spread of WNV as its distribution expands and to furtherdefine the modes of transmission and spread that are
important to the maintenance and evolution of this virus in
nature.Materials and methods
Strains
All newly sequenced WNV isolates came from a variety
of sources including birds, mosquitoes, horses, and humans
as described previously (Lillibridge et al., 2004; Davis et al.,
2003). A total of 74 isolates were collected from several
locations including Texas, Nebraska, Ohio, Indiana, Illinois,
Georgia, Florida, Louisiana, Arizona, California, Colorado,
Mexico, and Canada (Table 1).
RT-PCR
The prM and E genes of each isolate and complete
genomes of 25 isolates were sequenced by RT-PCR from
RNA extracted from infected tissues, cell culture super-
natants of original isolations, or supernatants after a single
passage in African green monkey (Vero) cell culture. RT-
PCR protocols, primer sequences, and sequencing methods
have been described elsewhere and are available upon
request (Davis et al., 2003, 2004).
Phylogenetic analysis
Following completion of either partial or complete
genome sequencing, nucleotide and deduced amino acid
sequences were aligned with sequences from other WNV
isolates found in GenBank which represented homologous
sequence regions. The AlignX program of the Vector NTI
Suite software package (Informax, Frederick, MD) was used
to generate all alignments. The GenBank accession numbers
for isolates used in the generation of phylogenetic trees are
found in each figure. Bayesian analysis was used to generate
a phylogenetic tree based on the prM–E alignment of the 74
newly sequenced North American WNV isolates with other
North American WN viruses available in GenBank and
rooted with the most closely related Old World WNV, Israel-
1998 (Accession no. AY033389) in order to create a tree
illustrating more parsimony informative sites. Phylogenies
were generated by the program MRBAYES (Version 2.0)
(Huelsenbeck and Ronquist, 2001) using the Metropolis
coupled Markov chain Monte Carlo algorithm run with four
chains over 150,000 generations under a general time-
reversible model with a burn-in time of 50,000 generations.
Rate heterogeneity was estimated using a g distribution for
the variable sites. The consensus phylogram among the 108
WNV isolates analyzed was then generated from the
MRBAYES output file using PAUP (Version 4.0b11,
Sinauer Associates, Sunderland, MA) with clade credibility
values at relevant nodes to demonstrate statistical support
C.T. Davis et al. / Virology 342 (2005) 252–265264for each clade. The Bayesian consensus tree was compared
to trees generated by neighbor-joining and maximum
parsimony analyses using PAUP in order to determine if
similar tree topologies were generated using different
methods. Additional phylogenetic trees were generated
from alignments of complete genomes or individual
genesntranslated regions (5VUTR, Capsid, prM, E, NS1,
NS2A, NS2B, NS3, NS4A, NS4B, NS5, and 3VUTR)
comparing the 25 completely sequenced isolates to all other
WNV complete genome sequences available in GenBank.
Maximum likelihood analysis was used to generate all
additional trees using PAUP under the general time-
reversible model with a g distribution of substitution rates.
Confirmation of tree topology was done using maximum
parsimony and neighbor-joining methods with statistical
support for relevant clades provided by 500 bootstrap
replicates using the neighbor-joining analysis.Acknowledgments
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